Bienaime Jean Jacques's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed Feb 12, 2024
- Accession no.
- 0001048477-24-000010
- Filed
- Feb 12, 2024
- Trade date
- Jan 18-Feb 9, 2024
- Filing delay
- 25 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.67M. It was filed 25 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bienaime Jean JacquesCIK 0001221590 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 18, 2024 | Common Stock | LLess common codeAcquired | +40 | $92.60 | +$3,704 | 419,602 | Direct | |
| Feb 8, 2024 | Common Stock | MOption exerciseAcquired | +15,000 | $63.10 | +$946,500 | 434,602 | Direct | |
| Feb 8, 2024 | Common Stock | SSaleDisposed | −15,000 | $89.77 | −$1,346,550 | 419,602 | Direct | |
| Feb 9, 2024 | Common Stock | MOption exerciseAcquired | +15,000 | $63.10 | +$946,500 | 434,602 | Direct | |
| Feb 9, 2024 | Common Stock | SSaleDisposed | −15,000 | $88.28 | −$1,324,200 | 419,602 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 146,000 | Direct | |
| Feb 9, 2024 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 131,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.